Can we better identify thin cutaneous melanomas that are likely to metastasize and cause death?

Annals of Surgical Oncology

Volumn 19, Issue 11, 2012, Pages 3310-3312

  Murali, Rajmohan ^a   Scolyer, Richard A ^b,c,d   Thompson, John F ^b,c,d  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c MELANOMA INSTITUTE AUSTRALIA   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; AUSTRALIA; CANCER CENTER; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CASE CONTROL STUDY; CAUSE OF DEATH; CUTANEOUS MELANOMA; DISTANT METASTASIS; EDITORIAL; FOLLOW UP; HUMAN; MITOSIS RATE; ONCOLOGICAL PARAMETERS; PATIENT COUNSELING; PRIMARY TUMOR; THIN CUTANEOUS MELANOMA;

AGE FACTORS; HUMANS; MALE; MELANOMA; MITOTIC INDEX; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RISK FACTORS; SEX FACTORS; SKIN NEOPLASMS;

EID: 84868194484     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2470-8     Document Type: Editorial

References (18)

1. Kalady MF, White RR, Johnson JL, et al. Thin melanomas: Predictive lethal characteristics from a 30-year clinical experience. Ann Surg. 2003;238:528-35.
2. Salman SM, Rogers GS. Prognostic factors in thin cutaneous malignant melanoma. J Dermatol Surg Oncol. 1990;16:413-8. (Pubitemid 20184347)
3. Mansson-Brahme E, Carstensen J, Erhardt K, et al. Prognostic factors in thin cutaneous malignant melanoma. Cancer. 1994;73:2324-32. (Pubitemid 24129115)
4. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199-206.
5. McKinnon JG, Yu XQ, McCarthy WH, Thompson JF. Prognosis for patients with thin cutaneous melanoma: Long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit. Cancer. 2003;98:1223-31. (Pubitemid 37099907)
6. Gimotty PA, Guerry D, Ming ME, et al. Thin primary cutaneous malignant melanoma: A prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. J Clin Oncol. 2004;22:3668-76. (Pubitemid 41095205)
7. Reintgen C, Shivers S, Reintgen M, et al. The changing face of malignant melanoma. J Surg Oncol. 2010;101:443-6.
8. Crocetti E, Caldarella A, Chiarugi A, et al. The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past. Melanoma Res. 2010;20:422-6.
9. Leiter U, Buettner PG, Eigentler TK, Garbe C. Prognostic factors of thin cutaneous melanoma: An analysis of the central malignant melanoma registry of the German Dermatological Society. J Clin Oncol. 2004;22:3660-7. (Pubitemid 41095204)
10. Guitart J, Lowe L, Piepkorn M, et al. Histological characteristics of metastasizing thin melanomas: A case-control study of 43 cases. Arch Dermatol. 2002;138:603-8.
11. Green AC, Baade P, Coory M, Aitken JF, Smithers M. Population- based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia. J Clin Oncol. 2012;30:1462-7.
12. Murali R, Haydu LE, Long GV, et al. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma. Ann Surg Oncol. 2012;19:1782-9.
13. Balch CM, Balch GC, Sharma RR. Identifying early melanomas at higher risk for metastases. J Clin Oncol. 2012;30:1406-7.
14. Thompson JF, Soong SJ, Balch CM, et al. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: An analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol. 2011;29:2199-205.
15. Gimotty PA, Elder DE, Fraker DL, et al. Identification of highrisk patients among those diagnosed with thin cutaneous melanomas. J Clin Oncol. 2007;25:1129-34. (Pubitemid 46596766)
16. Han D, Marzban SS, Yu D, et al. Sentinel node biopsy is indicated for thin melanomas C0.76 mm. Ann Surg Oncol. 2012;19(Suppl 1):S24.
17. Murali R, Haydu LE, Quinn MJ, et al. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma. Ann Surg. 2012;255:128-33.
18. Turner RM, Bell KJ, Morton RL, et al. Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanoma. J Clin Oncol. 2011;29:4641-6.